Valuation and rating: We assign a PE multiple of 32x (premium to other chemical companies as discussed above) on Sept'23 earnings of Rs110 post which we arrive at a target of Rs.3,520, an upside of 15% from the current levels. The company sees demand remaining steady, while logistic issues could pose a challenge in the short term. We see new product launches will drive growth in the future. Commissioning of CAPEX in Sep'21...